CRC-infiltrating CD30+OX40+ Tregs exhibited a prognostic value, whereas their CD30+OX40– and CD30−OX40+ counterparts did not, and could serve as a biomarker for predicting patient survival. Here, TNFRSF4 is linked to colorectal carcinoma.